New Type 1 Diabetes Treatment Approved – More Expansive Screening Needed?
With the approval of Tzield (teplizumab-mzwv), an anti-CD3 monoclonal antibody, we can now offer children 8 years and older an opportunity to delay the progression to type 1 diabetes for … Continue reading New Type 1 Diabetes Treatment Approved – More Expansive Screening Needed?
Question of the Week | Prediabetes after GDM-What do the Standards Recommend?
LR experienced gestational diabetes with their third pregnancy and now, at age 41, was just diagnosed with prediabetes. LR’s BMI is 29.3 and she is trying to lose weight. Based … Continue reading Question of the Week | Prediabetes after GDM-What do the Standards Recommend?
Our Spreading the Love Sale Ends Today! Save 15% on Online Bundles and our Virtual Diabetes Ed Training Conference.
To celebrate, we are spreading the love with a 15% discount off ALL Online Courses & Virtual Conference from Feb 10-17, 2023. Use code LOVE15 at checkout. Want to learn more about … Continue reading Our Spreading the Love Sale Ends Today! Save 15% on Online Bundles and our Virtual Diabetes Ed Training Conference.
Rationale of the Week | Low blood sugars and Beer
For last week’s practice question, we quizzed participants on low blood sugars and beer. 38% of respondents chose the best answer. We want to clarify and share this important information, … Continue reading Rationale of the Week | Low blood sugars and Beer
New “Zavvy” SGLT-2 Inhibitor Approved
There are now five SGLT-2 Inhibitors that are FDA approved for the treatment of diabetes. The latest one is bexagliflozin (Brenzavvy). We created the chart below to summarize the features … Continue reading New “Zavvy” SGLT-2 Inhibitor Approved
Question of the Week | February 14, 2023
Click Here to Test your Knowledge Happy Valentine’s Day, to show our love and appreciation, we are offering 15% off all Online Courses! Our annual Valentine’s sale is our way … Continue reading Question of the Week | February 14, 2023
Rationale of the Week | Safe for Surgery?
For last week’s practice question, we quizzed participants on the best action for a safe surgery. 51% of respondents chose the best answer. We want to clarify and share this … Continue reading Rationale of the Week | Safe for Surgery?
$35 Cap on Insulin for Medicare Recipients?
Starting in 2023, the Inflation Reduction Act, limits insulin out-of-pocket costs at $35 for a month for each insulin product covered by an individual’s Medicare Part D prescription drug plan or Medicare … Continue reading $35 Cap on Insulin for Medicare Recipients?
